Spots Global Cancer Trial Database for A Study to Evaluate Subcutaneous Zilucoplan in Pediatric Participants With Generalized Myasthenia Gravis
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Study to Evaluate Subcutaneous Zilucoplan in Pediatric Participants With Generalized Myasthenia Gravis
Official Title: A Multicenter Open-Label, Uncontrolled Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, Tolerability, and Activity of Zilucoplan in Pediatric Study Participants From 2 to Less Than 18 Years of Age With Acetylcholine Receptor Antibody Positive Generalized Myasthenia Gravis
Study ID: NCT06055959
Conditions
Interventions
Study Description
Brief Summary: The purpose of this study is to assess the pharmacokinetics, pharmacodynamics, safety, tolerability, immunogenicity and activity of zilucoplan (ZLP) in pediatric study participants with generalized myasthenia gravis (gMG).
Detailed Description:
Eligibility
Minimum Age: 12 Years
Eligible Ages: CHILD
Sex: ALL
Healthy Volunteers: No
Locations
Mg0014 50574, Denton, Texas, United States
Mg0014 40144, Milano, , Italy
Mg0014 20104, Seoul, , Korea, Republic of
Mg0014 20220, Seoul, , Korea, Republic of
Contact Details
Name: UCB Cares
Affiliation: 001 844 599 2273
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
